-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...

-Down to Earth Doctors will now have to prescribe only those medicines and procedures that have been listed under schemes Here is some good news for all the senior citizens in Delhi. From September 1, 2014, they can avail free consultation under 20 Central Government Health Schemes (CGHS). On Friday, the Union Minister of Health and Family Welfare, Harsh Vardhan, unveiled a pilot project that can be extended further in future. "This is...

-The Times of India MUMBAI: Treatment for HIV patients across India has taken a hit, especially in Delhi and Mumbai, due to severe stock-outs of life-saving medicines reported at government-owned centres. Shortage of first-line (initial), second-line (advanced) and paediatric HIV drugs, besides crucial diagnostic kits, has prompted patient groups to send a legal notice to the government, pointing to the scarcity, gaps in procurement and supply of these drugs. The treatment and control...

-The Times of India NEW DELHI: When it comes to healthcare, some are more equal than others for the government. Under the Central Government Health Scheme (CGHS) which covers central government employees, including serving and retired babus, current and ex-members of Parliament and the judiciary, the annual per capita expenditure is more than Rs 5,000. In contrast, the National Rural Health Mission (NRHM), which caters to the rural masses, spends just...